The optimization of needle electrode number and placement for irreversible electroporation of hepatocellular carcinoma

Radiology and Oncology

Volumn 46, Issue 2, 2012, Pages 126-135

  Adeyanju, Oyinlolu O ^a   Al Angari, Haitham M ^a   Sahakian, Alan V ^a  

^a NONE

Author keywords

electrode configuration; hepatocellu lar carcinoma; irreversible electroporation; optimization

Indexed keywords

ARTICLE; ELECTRIC FIELD; ELECTRODE; ELECTROPORATION; FINITE ELEMENT ANALYSIS; GEOMETRY; HUMAN; HUMAN TISSUE; IRREVERSIBLE ELECTROPORATION; LIVER CELL CARCINOMA; OUTCOME ASSESSMENT; TUMOR ABLATION; TUMOR VOLUME;

EID: 84861902570     PISSN: 13182099     EISSN: 15813207     Source Type: Journal    
DOI: 10.2478/v10019-012-0026-y     Document Type: Article

References (47)

1. World health organization: Cancer. World Health Organization. 2012. Accessed: March 12, 2012. Available from: http://www.who.int/mediacentre/ factsheets/fs297/en/index.html
2. Gomaa AI, Khan SA, Toledano MB, Waked I, Taylor-Robinson SD. Hepatocellular carcinoma: Epidemiology, risk factors and pathogenesis. World J Gastroenterol 2008; 14: 4300-8
3. Medicine Net: Liver cancer. Stoppler, M. 2011. Accessed: March 12, 2012. Available from: http://www.medicinenet.com/liver-cancer/article.htm
4. Forner A, Llovet JM, Bruix J. Hepatocellular carcinoma. Lancet 2012; Epub ahead of print.
5. Davalos RV, Mir IL, Rubinsky B. Tissue ablation with irreversible electroporation. Ann Biomed Eng 2005; 33: 223-31. (Pubitemid 40496051)
6. Daniels C, Rubinsky B. Electrical field and temperature model of nonthermal irreversible electroporation in heterogeneous tissues. J Biomech Eng 2009; 131: 071006.
7. Rubinsky B. Irreversible electroporation in medicine. Technol Cancer Res Treat 2007; 6: 255-60.
8. Rubinsky B, Onik G, Mikus P. Irreversible electroporation: A new ablation modality - clinical implications. Technol Cancer Res Treat 2007; 6: 37-48. (Pubitemid 46389347)
9. Hofmann GA. Instrumentation and electrodes for in vivo electroporation. In. Jaroszeski MJ, Heller R, Gilbert R, editors. Electrochemotherapy, electrogenetherapy, and transdermal drug delivery. Electrically mediated delivery of molecules to cells. Totowa, New Jersey: Humana Press, 2000. p. 37-61.
10. Sel D, Mazeres S, Teissie J, Miklavcic D. Finite-element modeling of needle electrodes in tissue from the perspective of frequent model computation. IEEE Trans Biomed Eng 2003; 50: 1221-32. (Pubitemid 37339397)
11. Miklavcic D, Beravs K, Semrov D, Cemazar M, Demsar F, Sersa G. The importance of electric field distribution for effective in vivo electroporation of tissues. Biophys J 1998; 74: 2152-8. (Pubitemid 28225212)
12. Gilbert RA, Jaroszeski MJ, Heller R. Novel electrode designs for electrochemotherapy. Biochim Biophys Acta 1997; 1334: 9-14. (Pubitemid 27063940)
13. Sersa G, Cemazar M, Semrov D, Miklavcic D. Changing electrode orientation improves the efficacy of electrochemotherapy of solid tumors in mice. Bioelectrochem Bioenerg 1996; 39: 61-6. (Pubitemid 26050126)
14. Corovic S, Pavlin M, Miklavcic D. Analytical and numerical quantification and comparison of the local electric field in the tissue for different electrode configurations. Biomed Eng Online 2007; 6: 37.
15. Cindea NBF, Gournay F, Poignard C. Optimal placement of electrodes in an electroporation process. ESAIM: Proceedings 2010; 30: 34-43.
16. Zupanic A, Corovic S, Miklavcic D. Optimization of electrode position and electric pulse amplitude in electrochemotherapy. Radiol Oncol 2008; 42: 93-101. (Pubitemid 351841993)
17. Brandisky K, Daskalov I. Electrical field and current distributions in electrochemotherapy. Bioelectrochem Bioenerg 1999; 48: 201-8. (Pubitemid 29150380)
18. Corovic S, Zupanic A, Miklavcic D. Numerical modeling and optimization of electric field distribution in subcutaneous tumor treated with electrochemotherapy using needle electrodes. IEEE Transactions on Plasma Science 2008; 36: 1665-72.
19. Miklavcic D, Semrov D, Mekid H, Mir LM. A validated model of in vivo electric field distribution in tissues for electrochemotherapy and for DNA electrotransfer for gene therapy. Biochim Biophys Acta 2000; 1523: 73-83.
20. Zupanic A, Corovic S, Miklavcic D, Pavlin M. Numerical optimization of gene electrotransfer into muscle tissue. Biomed Eng Online 2010; 9: 66.
21. Kos B, Zupanic A, Kotnik T, Snoj M, Sersa G, Miklavcic D. Robustness of treatment planning for electrochemotherapy of deep-seated tumors. J Membr Biol 2010; 236: 147-53.
22. Miklavcic D, Snoj M, Zupanic A, Kos B, Cemazar M, Kropivnik M, Bracko M, Pecnik T, Gadzijev E, Sersa G. Towards treatment planning and treatment of deep-seated solid tumors by electrochemotherapy. Biomed Eng Online 2010; 9: 10.
23. Sel D, Lebar AM, Miklavcic D. Feasibility of employing model-based optimization of pulse amplitude and electrode distance for effective tumor electropermeabilization. IEEE Trans Biomed Eng 2007; 54: 773-81. (Pubitemid 46628559)
24. Rubinsky B. Irreversible electroporation. Springer. Series in biomedical engineering. 2009. pp 203-217
25. Zupanic A, Miklavcic D. Method for treatment planning of tissue ablation by irreversible electroporation. In: Dössel O, Schlegel WC, eds. World congress on medical physics and biomedical engineering, september 7-12, 2009, Munich, Germany. Springer Berlin Heidelberg; 2009:150-153.
26. Edd JF, Horowitz L, Davalos RV, Mir LM, Rubinsky B. In vivo results of a new focal tissue ablation technique: Irreversible electroporation. IEEE Trans Biomed Eng 2006; 53: 1409-15. (Pubitemid 44172315)
27. Arrive L, Rosmorduc O, Dahan H, Fartoux L, Monnier-Cholley L, Lewin M, et al. Percutaneous acetic acid injection for hepatocellular carcinoma: Using ct fluoroscopy to evaluate distribution of acetic acid mixed with an iodinated contrast agent. AJR Am J Roentgenol. 2003; 180: 159-62. (Pubitemid 36008703)
28. Duck FA. Physical properties of tissue. San Diego: Academic Press Inc; 1990. p. 138
29. Elwassif MM, Kong Q, Vazquez M, Bikson M. Bio-heat transfer model of deep brain stimulation-induced temperature changes. J Neural Eng 2006; 3: 306-15.
30. Laufer S, Ivorra A, Reuter VE, Rubinsky B, Solomon SB. Electrical impedance characterization of normal and cancerous human hepatic tissue. Physiol Meas 2010; 31: 995-1009.
31. Sel D, Cukjati D, Batiuskaite D, Slivnik T, Mir LM, Miklavcic D. Sequential finite element model of tissue electropermeabilization. IEEE Trans Biomed Eng 2005; 52: 816-27. (Pubitemid 40675481)
32. Ivorra A, Al-Sakere B, Rubinsky B, Mir LM. In vivo electrical conductivity measurements during and after tumor electroporation: Conductivity changes reflect the treatment outcome. Phys Med Biol 2009; 54: 5949-63.
33. Haemmerich D, Schutt DJ, Wright AW, Webster JG, Mahvi DM. Electrical conductivity measurement of excised human metastatic liver tumours before and after thermal ablation. Physiol Meas 2009; 30: 459-66.
34. Deng ZS, Liu, J. Blood perfusion-based model for characterizing the temperature fluctuation in living tissues. Physica A: Statistical Mechanics and its Applications 2001; 300: 521-30.
35. Bertacchini C, Margotti PM, Bergamini E, Lodi A, Ronchetti M, Cadossi R. Design of an irreversible electroporation system for clinical use. Technol Cancer Res Treat 2007; 6: 313-20. (Pubitemid 47340124)
36. Edd JF, Davalos RV. Mathematical modeling of irreversible electroporation for treatment planning. Technol Cancer Res Treat 2007; 6: 275-86. (Pubitemid 47340119)
37. Gundersen M, Vernier PT, Marcu L, Li A, Zhu X, Gallam AZ, et al. Ultrashort pulse electroporation: Applications of high pulsed electric fields to induced caspase activation of human lymphocytes. Power Modulator Symposium, 2002 and 2002 High-Voltage Workshop. Conference Record of the Twenty-Fifth International 2002
38. Cabibbo G, Craxi A. Needle track seeding following percutaneous procedures for hepatocellular carcinoma. World J Hepatol 2009; 1: 62-6.
39. Tezcan Y, Mehmet, K. Hepatocellular carcinoma with subcutaneous metastasis of the scalp. Radiol Oncol 2011; 45: 292-5.
40. Narayanan G. Irreversible electroporation for treatment of liver cancer. Gastroenterol Hepatol (N Y) 2011; 7: 313-6.
41. Granot Y, Ivorra A, Maor E, Rubinsky B. In vivo imaging of irreversible electroporation by means of electrical impedance tomography. Phys Med Biol 2009; 54: 4927-43.
42. Zhang Y, Guo Y, Ragin AB, Lewandowski RJ, Yang GY, Nijm GM, et al. Mr imaging to assess immediate response to irreversible electroporation for targeted ablation of liver tissues: Preclinical feasibility studies in a rodent model. Radiology 2010; 256: 424-32.
43. Kranjc M, Bajd F, Sersa I, Miklavcic D. Magnetic resonance electrical impedance tomography for monitoring electric field distribution during tissue electroporation. IEEE Trans Med Imaging 2011; 30: 1771-8.
44. Hjouj M, Rubinsky B. Magnetic resonance imaging characteristics of non-thermal irreversible electroporation in vegetable tissue. J Membr Biol 2010; 236: 137-46.
45. Miklavcic D, Towhidi, L. Numerical study of the electroporation pulse shape effect on molecular uptake of biological cells. Radiol Oncol 2010; 44: 34-41.
46. Sahakian AV, Al-Angari HM, Adeyanju OO. Electrode activation sequencing employing conductivity changes in irreversible electroporation tissue ablation. IEEE Trans Biomed Eng 2012; 59: 604-7.
47. Zupanic A, Miklavcic, D. Tissue heating during tumor ablation with irreversible electroporation. Elektrotehniski Vestnik 2011; 78: 42-7.